What's new in IDIS/Web:

 • New Drugs

 • New Diseases

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - October 2011

NEW DRUG TERM
ANRUKINZUMAB
APOLIZUMAB
AT-7519
AVI-4658
BIRCH BARK EXTRACT
BMS-747158
CARBON C 11 4DST
CAT-3888
COPPER GLUCONATE
DCC-2036
DOTA-BASS
GFT-505
GW-468816
IMA-026
LBM-415
LEBRIKIZUMAB
LY-2334737
MK-0752
MKC-1106-PP
MOXETUMOMAB PASUDOTOX
OXALOBACTER FORMIGENES
PEGINTERFERON LAMBDA
PF-734200
SB-656933
SIRUKUMAB
TC 99M HYNIC-TOC
TENIFATECAN

CODE
82000555
10120288
10120998
92000372
92510281
36680123
36680121
10120996
40120414
10120994
36680122
68200445
95000352
82000554
8122953
82000556
10080436
44100107
10120639
10120997
92000373
14000209
68200027
14000080
82000553
78040274
10120995


NEW DISEASE TERM
SYNDROME, TUMOR LYSIS

CODE
277.88


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
AP-24534 10120940PONATINIB 10120940
ARQ-197 10120981TIVANTINIB 10120981
BAY-949172 36680106FLORBETABEN 36680106
CP-690550 92000307TASOCITINIB 92000307
DMXAA 10120225VADIMEZAN 10120225
CK-1827452 24040502OMECAMTIV MECARBIL 24040502


FDA APPROVAL PACKAGES

Article Numbers 664113-664128: Vemurafenib, Zelboraf, FDA Approval Package for NDA 202429. FDA Approval Package 2011.

Article Numbers 664097-664112: Ticagrelor, Brilinta, FDA Approval Package for NDA 022433. FDA Approval Package 2011.


ADVISORY COMMITTEE MEETINGS

Article Numbers 664088-664096: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, September 9, 2011. FDA Advisory Committee 2011.

Article Numbers 664081-664087: Oncologic Drugs Advisory Committee Meeting, September 14, 2011. FDA Advisory Committee 2011.

Article Numbers 664075-664080: Cardiovascular and Renal Drugs Advisory Committee Meeting, September 8, 2011. FDA Advisory Committee 2011.

Article Numbers 664069-664074: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting, June 17, 2011. FDA Advisory Committee 2011.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 664063: Anonymous. Full Guideline. Hypertension: Clinical Management of Primary Hypertension in Adults. NICE Clinical Guideline No. 127 (Ref Art 664063-664066). NICE Clin Guidel 2011.


CONTINUING EDUCATION ARTICLES

Article Number 664438: Anonymous. Peginterferon Alfa-2b (Sylatron) for Melanoma (0.1 CEU) [ IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 664436-664438]. Med Lett Drugs Ther 2011, 53:76.

Article Number 664437: Anonymous. Adjunctive Antipsychotics for Major Depression (0.1 CEU) [ IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 664436-664438]. Med Lett Drugs Ther 2011, 53:74-75.

Article Number 664436: Anonymous. Fidaxomicin (Dificid) for Clostridium Difficile Infection (0.1 CEU) [ IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 664436-664438]. Med Lett Drugs Ther 2011, 53:73-74.

Article Number 664400: Anonymous. Antithrombotic Drugs. Treat Guidel Med Lett 2011, 9:61-66.

Article Number 664335: Cada D J, Baker D E, Levien T L. Linagliptin (0.15 CEU). Hosp Pharm 2011, 46:685-695.

Article Number 663039: Anonymous. Drugs for Peptic Ulcer Disease and GERD (0.2 CEU). Treat Guidel Med Lett 2011, 9:55-60.


College of Pharmacy